Morten Agertoug Nielsen
Nielsen, Morten Agertoug
VIAF ID: 5412148390881710830009 (Personal)
Permalink: http://viaf.org/viaf/5412148390881710830009
Preferred Forms
- 100 0 _ ‡a Morten Agertoug Nielsen
- 100 1 _ ‡a Nielsen, Morten Agertoug
4xx's: Alternate Name Forms (3)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
4-Aminoquinoline derivatives: Synthesis, in vitro and in vivo antiplasmodial activity against chloroquine-resistant parasites | |
Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses | |
Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration | |
Can any lessons be learned from the ambiguous glycan binding of PfEMP1 domains? | |
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity | |
The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains | |
Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites | |
Cryo-EM reveals the architecture of placental malaria VAR2CSA and provides molecular insight into chondroitin sulfate binding | |
Differential adhesion-inhibitory patterns of antibodies raised against two major variants of the NTS-DBL2X region of VAR2CSA. | |
Differential induction of immunoglobulin G to Plasmodium falciparum variant surface antigens during the transmission season in Daraweesh, Sudan. | |
The effect of adjuvants on the immune response induced by a DBL4ɛ-ID4 VAR2CSA based Plasmodium falciparum vaccine against placental malaria. | |
Ethnomedicinal survey and in vitro anti-plasmodial activity of the palm Borassus aethiopum Mart | |
Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies | |
High-Throughput Testing of Antibody-Dependent Binding Inhibition of Placental Malaria Parasites | |
Identification and characterization of B-cell epitopes in the DBL4ε domain of VAR2CSA | |
Identification of a Major Dimorphic Region in the Functionally Critical N-Terminal ID1 Domain of VAR2CSA. | |
Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display | |
Mannose-Binding Lectin Is a Disease Modifier in Clinical Malaria and May Function as Opsonin for Plasmodium falciparum- Infected Erythrocytes. | |
Marchantin A, a macrocyclic bisbibenzyl ether, isolated from the liverwort Marchantia polymorpha, inhibits protozoal growth in vitro | |
Multilaboratory approach to preclinical evaluation of vaccine immunogens for placental malaria | |
Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen | |
The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A. | |
Persistent Plasmodium falciparum infection in women with an intent to become pregnant is a risk factor for pregnancy-associated malaria. | |
Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum. | |
Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1 | |
Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes | |
Plasmodium falciparum expressing domain cassette 5 type PfEMP1 (DC5-PfEMP1) bind PECAM1. | |
Plasmodium falciparum infection early in pregnancy has profound consequences for foetal growth | |
Plasmodium falciparum: VAR2CSA expressed during pregnancy-associated malaria is partially resistant to proteolytic cleavage by trypsin | |
Positive selection of Plasmodium falciparum parasites with multiple var2csa-type PfEMP1 genes during the course of infection in pregnant women | |
Pre-clinical and clinical development of the first placental malaria vaccine | |
Preferential transcription of conserved rif genes in two phenotypically distinct Plasmodium falciparum parasite lines. | |
Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin | |
Severe malaria is associated with parasite binding to endothelial protein C receptor | |
Specificity and cross-reactivity of Plasmodium falciparum variant surface antigen-specific antibody responses | |
Structural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA | |
Structure function analysis of P. falciparum VAR2CSA. | |
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein | |
An upstream open reading frame controls translation of var2csa, a gene implicated in placental malaria | |
Utilizing nanobody technology to target non-immunodominant domains of VAR2CSA. | |
A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice | |
VAR2CSA expression on the surface of placenta-derived Plasmodium falciparum-infected erythrocytes | |
The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner | |
Virus-like particle display of HER2 induces potent anti-cancer responses. |